Pharma Mar, S.A. (OTCMKTS:PHMMF) Short Interest Up 43.4% in February

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 32,700 shares, an increase of 43.4% from the February 13th total of 22,800 shares. Approximately 0.2% of the shares of the stock are short sold. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 327.0 days.

Pharma Mar Stock Performance

PHMMF stock opened at $102.08 on Friday. Pharma Mar has a 52 week low of $26.85 and a 52 week high of $105.60. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The business has a 50-day simple moving average of $92.24 and a 200 day simple moving average of $75.31.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.